Anagnostopoulos I, Hummel M, Finn T, Tiemann M, Korbjuhn P, Dimmler C, Gatter K, Dallenbach F, Parwaresch M R, Stein H
Institute for Pathology, Klinikum Steglitz, Free University Berlin, Germany.
Blood. 1992 Oct 1;80(7):1804-12.
In this study, 32 cases of T-cell lymphoma of angioimmunoblastic lymphadenopathy type (AILD-TCL) were investigated for their association with Epstein-Barr virus (EBV). For this purpose, three different approaches were applied: polymerase chain reaction (PCR) for the presence of EBV-DNA, in situ hybridization (ISH) for EBV-encoded small nuclear RNAs (EBER), and immunohistology for EBV-encoded latent membrane protein (LMP). PCR and EBER-ISH produced almost identical results, showing that all but one case of AILD-TCL contained EBV genomes. Three distinctive patterns of EBV infection were observed after immunophenotypical characterization of EBER-positive cells: (1) in 26% of the cases, B and T cells were infected, the majority of which were B cells of immunoblastic morphology located in the remnants of lymphoid follicles; (2) in 42% of the cases, the vast majority of infected cells were neoplastic T cells diffusely distributed in the lymph nodes, but infected B cells were also present; and (3) in 32% of the cases, there were only a few infected small lymphoid cells. Detectable LMP was frequent in cases exhibiting patterns 1 and 2. These findings suggest that in AILD-TCL patients, B cells and especially T cells are highly susceptible to a persistent EBV infection, which often leads to a growth advantage of the infected cells. Thus EBV, in conjunction with genetic abnormalities and selective defects of the immune system, might be involved in the pathogenesis of AILD-TCL.
在本研究中,对32例血管免疫母细胞性淋巴结病型T细胞淋巴瘤(AILD-TCL)患者进行了与爱泼斯坦-巴尔病毒(EBV)相关性的调查。为此,采用了三种不同的方法:聚合酶链反应(PCR)检测EBV-DNA的存在、原位杂交(ISH)检测EBV编码的小核RNA(EBER)以及免疫组织化学检测EBV编码的潜伏膜蛋白(LMP)。PCR和EBER-ISH产生了几乎相同的结果,表明除1例AILD-TCL外,所有病例均含有EBV基因组。在对EBER阳性细胞进行免疫表型特征分析后,观察到三种不同的EBV感染模式:(1)在26%的病例中,B细胞和T细胞均被感染,其中大多数是位于淋巴滤泡残余部位的免疫母细胞形态的B细胞;(2)在42%的病例中,绝大多数被感染细胞是弥漫分布于淋巴结中的肿瘤性T细胞,但也存在被感染的B细胞;(3)在32%的病例中,仅有少数被感染的小淋巴细胞。在表现出模式1和2的病例中,可检测到的LMP很常见。这些发现表明,在AILD-TCL患者中,B细胞尤其是T细胞对持续性EBV感染高度易感,这通常会导致被感染细胞的生长优势。因此,EBV可能与遗传异常和免疫系统的选择性缺陷共同参与了AILD-TCL的发病机制。